IRIS Accounts Production v25.1.4.42 07200710 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 28385 44305 19775 16232 15317 312 23927 28385 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072007102024-03-31072007102025-03-31072007102024-04-012025-03-31072007102023-03-31072007102023-04-012024-03-31072007102024-03-3107200710ns15:EnglandWales2024-04-012025-03-3107200710ns14:PoundSterling2024-04-012025-03-3107200710ns10:Director12024-04-012025-03-3107200710ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107200710ns10:SmallEntities2024-04-012025-03-3107200710ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107200710ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107200710ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107200710ns10:FullAccounts2024-04-012025-03-310720071012024-04-012025-03-3107200710ns10:OrdinaryShareClass12024-04-012025-03-3107200710ns10:OrdinaryShareClass22024-04-012025-03-3107200710ns10:Director2422024-03-3107200710ns10:Director2422023-03-3107200710ns10:Director2422024-04-012025-03-3107200710ns10:Director2422023-04-012024-03-3107200710ns10:Director2422025-03-3107200710ns10:Director2422024-03-3107200710ns5:CurrentFinancialInstruments2025-03-3107200710ns5:CurrentFinancialInstruments2024-03-3107200710ns5:ShareCapital2025-03-3107200710ns5:ShareCapital2024-03-3107200710ns5:RetainedEarningsAccumulatedLosses2025-03-3107200710ns5:RetainedEarningsAccumulatedLosses2024-03-3107200710ns10:RegisteredOffice2024-04-012025-03-3107200710ns5:NetGoodwill2024-04-012025-03-3107200710ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107200710ns5:FurnitureFittings2024-04-012025-03-3107200710ns5:MotorVehicles2024-04-012025-03-3107200710ns5:NetGoodwill2024-03-3107200710ns5:NetGoodwill2025-03-3107200710ns5:NetGoodwill2024-03-3107200710ns5:FurnitureFittings2024-03-3107200710ns5:MotorVehicles2024-03-3107200710ns5:FurnitureFittings2025-03-3107200710ns5:MotorVehicles2025-03-3107200710ns5:FurnitureFittings2024-03-3107200710ns5:MotorVehicles2024-03-3107200710ns5:DeferredTaxation2024-03-3107200710ns5:DeferredTaxation2024-04-012025-03-3107200710ns5:DeferredTaxation2025-03-3107200710ns10:OrdinaryShareClass12025-03-3107200710ns10:OrdinaryShareClass22025-03-3107200710ns10:Director22024-04-012025-03-31072007101ns10:Director12024-03-31072007101ns10:Director12023-03-31072007101ns10:Director12024-04-012025-03-31072007101ns10:Director12023-04-012024-03-31072007101ns10:Director12025-03-31072007101ns10:Director12024-03-31
REGISTERED NUMBER: 07200710 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Raine Anaesthetic Enterprises Ltd

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Balance Sheet 1

Notes to the Financial Statements 3


Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 31,490 37,789
Tangible assets 5 34,984 49,178
66,474 86,967

CURRENT ASSETS
Debtors 6 28,732 -
Cash at bank 354,263 260,782
382,995 260,782
CREDITORS
Amounts falling due within one year 7 63,485 38,392
NET CURRENT ASSETS 319,510 222,390
TOTAL ASSETS LESS CURRENT
LIABILITIES

385,984

309,357

PROVISIONS FOR LIABILITIES 8 6,647 567
NET ASSETS 379,337 308,790

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 379,237 308,690
SHAREHOLDERS' FUNDS 379,337 308,790

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 July 2025 and were signed on its behalf by:





Dr G J Raine - Director


Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Raine Anaesthetic Enterprises Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07200710

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
OXford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2010, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Motor vehicles - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 125,970
AMORTISATION
At 1 April 2024 88,181
Amortisation for year 6,299
At 31 March 2025 94,480
NET BOOK VALUE
At 31 March 2025 31,490
At 31 March 2024 37,789

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 April 2024 6,149 58,350 64,499
Additions 1,399 - 1,399
Disposals (959 ) - (959 )
At 31 March 2025 6,589 58,350 64,939
DEPRECIATION
At 1 April 2024 3,165 12,156 15,321
Charge for year 1,005 14,588 15,593
Eliminated on disposal (959 ) - (959 )
At 31 March 2025 3,211 26,744 29,955
NET BOOK VALUE
At 31 March 2025 3,378 31,606 34,984
At 31 March 2024 2,984 46,194 49,178

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 28,732 -

Raine Anaesthetic Enterprises Ltd (Registered number: 07200710)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Tax 38,079 7,519
Social security and other taxes 279 160
Directors' current accounts 23,927 28,386
Accrued expenses 1,200 2,327
63,485 38,392

8. PROVISIONS FOR LIABILITIES
31.3.25 31.3.24
£    £   
Deferred tax 6,647 567

Deferred
tax
£   
Balance at 1 April 2024 567
Provided during year 6,080
Balance at 31 March 2025 6,647

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
50 Ordinary A o1 50 50
50 Ordinary B o1 50 50
100 100

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Dr G J Raine and Mrs D N Raine
Balance outstanding at start of year (28,385 ) (44,305 )
Amounts advanced 19,775 16,232
Amounts repaid (15,317 ) (312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (23,927 ) (28,385 )

11. ULTIMATE CONTROLLING PARTY

The controlling party is the directors.